Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder.
Claudia FuchsLivia CosentinoChiara UrbinatiMaria Cristina TalamoGiorgio MediciMaria Cristina QuattriniNicola MottoleseDonatella PietraforteAndrea FusoElisabetta CianiBianca De FilippisPublished in: CNS neuroscience & therapeutics (2022)
Present results provide evidence that PAKs may represent innovative therapeutic targets for CDD.
Keyphrases